195 related articles for article (PubMed ID: 28870821)
1. Self-Made, Cost-Reducing Hemostatic Agent for Use in Spine Surgery.
Alonso F; Rustagi T; Iwanaga J; Fisahn C; Oskouian R; Tubbs RS; Dailey A; Chapman JR
World Neurosurg; 2017 Dec; 108():90-93. PubMed ID: 28870821
[TBL] [Abstract][Full Text] [Related]
2. Cost-consequence analysis of a hemostatic matrix alone or in combination for spine surgery patients.
Ramirez MG; Niu X; Epstein J; Yang D
J Med Econ; 2018 Oct; 21(10):1041-1046. PubMed ID: 30112922
[TBL] [Abstract][Full Text] [Related]
3. Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients.
Makhija D; Rock M; Ikeme S; Kuntze E; Epstein JD; Nicholson G; Price JS; Patel V
J Med Econ; 2017 Jun; 20(6):606-613. PubMed ID: 28287015
[TBL] [Abstract][Full Text] [Related]
4. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
5. Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery.
Price JS; Tackett S; Patel V
J Med Econ; 2015; 18(10):777-86. PubMed ID: 25934148
[TBL] [Abstract][Full Text] [Related]
6. Similar patient outcomes yet different hospital costs between flowable hemostatic agents.
David G; Lim S; Gunnarsson C; Kocharian R; Roy S
J Med Econ; 2015; 18(9):735-45. PubMed ID: 25907200
[TBL] [Abstract][Full Text] [Related]
7. Gelatin Paste as an Alternative Cost-Effective Hemostatic Agent in Cranial Surgery: Doing More with Less.
Serrato-Avila JL; Navarro-Fernández JO; Hernández-Reséndiz R; Cacho-Díaz B; Reyes-Soto G; Monroy-Sosa A
World Neurosurg; 2019 Feb; 122():224-228. PubMed ID: 30415038
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a gelatin matrix as a topical hemostatic agent for hepatic bleeding in the dog.
Polidoro DP; Kass PH
J Am Anim Hosp Assoc; 2013; 49(5):308-17. PubMed ID: 23861265
[TBL] [Abstract][Full Text] [Related]
9. Floseal only versus in combination in spine surgery: a comparative, retrospective hospital database evaluation of clinical and healthcare resource outcomes.
Ramirez MG; Deutsch H; Khanna N; Cheatem D; Yang D; Kuntze E
Hosp Pract (1995); 2018 Oct; 46(4):189-196. PubMed ID: 29986148
[TBL] [Abstract][Full Text] [Related]
10. Topical hemostatic agents for bone bleeding in humans. A quantitative comparison of gelatin paste, gelatin sponge plus bovine thrombin, and microfibrillar collagen.
Harris WH; Crothers OD; Moyen BJ; Bourne RB
J Bone Joint Surg Am; 1978 Jun; 60(4):454-6. PubMed ID: 566756
[TBL] [Abstract][Full Text] [Related]
11. Use of topical hemostatic agents in gynecologic surgery.
Wysham WZ; Roque DR; Soper JT
Obstet Gynecol Surv; 2014 Sep; 69(9):557-63. PubMed ID: 25229825
[TBL] [Abstract][Full Text] [Related]
12. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
[TBL] [Abstract][Full Text] [Related]
13. Two-layer sheet of gelatin: A new topical hemostatic agent.
Takagi T; Tsujimoto H; Torii H; Ozamoto Y; Hagiwara A
Asian J Surg; 2018 Mar; 41(2):124-130. PubMed ID: 27816406
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery.
Cho SK; Yi JS; Park MS; Hu G; Zebala LP; Pahys JM; Kang MM; Lee DH; Riew KD
J Bone Joint Surg Am; 2012 Nov; 94(21):1952-8. PubMed ID: 23138237
[TBL] [Abstract][Full Text] [Related]
15. Cost-consequence analysis of different active flowable hemostatic matrices in cardiac surgical procedures.
Makhija D; Rock M; Xiong Y; Epstein JD; Arnold MR; Lattouf OM; Calcaterra D
J Med Econ; 2017 Jun; 20(6):565-573. PubMed ID: 28097913
[TBL] [Abstract][Full Text] [Related]
16. A review of three stand-alone topical thrombins for surgical hemostasis.
Cheng CM; Meyer-Massetti C; Kayser SR
Clin Ther; 2009 Jan; 31(1):32-41. PubMed ID: 19243705
[TBL] [Abstract][Full Text] [Related]
17. Gelatin-thrombin hemostatic matrix in neurosurgical procedures: hemostatic effectiveness and economic value of clinical and surgical procedure-related benefits.
Esposito F; Cappabianca P; Angileri FF; Cavallo LM; Priola SM; Crimi S; Solari D; Germanò AF; Tomasello F
J Neurosurg Sci; 2020 Apr; 64(2):158-164. PubMed ID: 27456032
[TBL] [Abstract][Full Text] [Related]
18. Topical haemostatics in renal trauma--an evaluation of four different substances in an experimental setting.
Björses K; Holst J
J Trauma; 2009 Mar; 66(3):602-11. PubMed ID: 19276727
[TBL] [Abstract][Full Text] [Related]
19. Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings.
Schreiber MA; Neveleff DJ
AORN J; 2011 Nov; 94(5):S1-20. PubMed ID: 22035823
[TBL] [Abstract][Full Text] [Related]
20. Absorbable hemostatic agents.
Gabay M
Am J Health Syst Pharm; 2006 Jul; 63(13):1244-53. PubMed ID: 16790576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
